McKesson to Acquire HCA's Personalized Medicine Software Unit
The unit, Genospace, uses genomic and other data to match and recruit patients for clinical trials and to guide clinical decision making.
Binx Health said that when it received FDA CLIA waiver, it already had a strategic partner for sales of its POC platform and chlamydia and gonorrhea tests.
Binx Health Inks US Distribution Agreement With McKesson for Chlamydia, Gonorrhea Testing Platform
Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA.
McKesson to Distribute Qiagen Syndromic Testing Platform in US
McKesson will be the exclusive distributor of the QiaStat-Dx system in US hospitals with fewer than 200 beds and non-exclusive distributor for future expansion into retail pharmacy clinics.
White House Announces Efforts to Accelerate Precision Medicine Initiative
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.